Equity Profile

LMAT

LeMaitre Vascular, Inc.

Health CareHealth Care Equipment$2.2B

Aug10Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, focusing on medical devices for vascular surgery....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Expected to be around $0.68

Revenue Growth

Revenue growth will indicate how well the company is expanding its market presence and sales, crucial for long-term sustainability.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

LMAT Q2-2026 Earnings Preview

Context

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, focusing on medical devices for vascular surgery. The company is significant as it addresses critical needs in vascular health, which is a growing concern in an aging population.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+4.17%

Avg Stock Reaction

-0.41%

Last Quarter Recap

In Q1-2026, LeMaitre reported an EPS of $0.68, slightly beating expectations. The stock reacted positively, gaining 0.42% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about LeMaitre's upcoming earnings, particularly given its recent performance. However, the lack of detailed guidance creates uncertainty.

Bull Case

If LeMaitre continues its trend of beating EPS estimates, it could signal strong operational performance and attract more investor interest.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

Expected to be around $0.68

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Revenue Growth

Not available

Revenue growth will indicate how well the company is expanding its market presence and sales, crucial for long-term sustainability.

Gross Margin

Not available

Gross margin reflects the efficiency of production and pricing strategy, which is vital for maintaining profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's history of beating EPS estimates, this number will be crucial for investor sentiment.

How is revenue growth trending in the current quarter?

Investors will closely watch revenue figures to gauge the company's market performance and growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating LeMaitre's ability to sustain its recent EPS growth, given its historical performance and market position.

Supporting Evidence

LeMaitre has beaten EPS estimates 75% of the time in the last 8 quarters.

The options market is pricing in a larger move than has historically been realized, suggesting heightened expectations.

Recent trends in the health care sector indicate a potential for continued growth in demand for vascular products.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether LeMaitre can sustain its recent performance amid competitive pressures and economic conditions.

Bull Confirmed If

An EPS of $0.70 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $0.65 would raise concerns about the company's profitability and growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±12.76%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a substantial move, suggesting that traders expect significant volatility around the earnings report.

Options are pricing ±3.1% while LMAT has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.4%

Calls (0)P/C Ratio: 12.00Puts (3K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 10 of 30 (33%)

This setup has occurred 30 times across Health Care in the last 2 years. 20 of 30 (67%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 5.0%, with a raw directional average of -0.2% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LeMaitre beats expectations, history suggests the stock could rise by around 0.06%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future guidance.

Miss

A miss could lead to a decline of about 1.80%, as seen in past reactions to earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in vascular technology.
2Details on market expansion strategies and geographic performance.
3Insights into cost management and gross margin trends.
4Management's outlook on competitive pressures in the health care equipment sector.
5Any commentary on regulatory changes affecting the industry.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Tempus AI, Inc.

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, focusing on medical devices for vascular surgery....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Expected to be around $0.68

Revenue Growth

Revenue growth will indicate how well the company is expanding its market presence and sales, crucial for long-term sustainability.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

LMAT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+4.17%

Avg Stock Reaction

-0.41%

Last Quarter Recap

In Q1-2026, LeMaitre reported an EPS of $0.68, slightly beating expectations. The stock reacted positively, gaining 0.42% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about LeMaitre's upcoming earnings, particularly given its recent performance. However, the lack of detailed guidance creates uncertainty.

Bull Case

If LeMaitre continues its trend of beating EPS estimates, it could signal strong operational performance and attract more investor interest.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

Expected to be around $0.68

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Revenue Growth

Not available

Revenue growth will indicate how well the company is expanding its market presence and sales, crucial for long-term sustainability.

Gross Margin

Not available

Gross margin reflects the efficiency of production and pricing strategy, which is vital for maintaining profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's history of beating EPS estimates, this number will be crucial for investor sentiment.

How is revenue growth trending in the current quarter?

Investors will closely watch revenue figures to gauge the company's market performance and growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating LeMaitre's ability to sustain its recent EPS growth, given its historical performance and market position.

Supporting Evidence

LeMaitre has beaten EPS estimates 75% of the time in the last 8 quarters.

The options market is pricing in a larger move than has historically been realized, suggesting heightened expectations.

Recent trends in the health care sector indicate a potential for continued growth in demand for vascular products.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether LeMaitre can sustain its recent performance amid competitive pressures and economic conditions.

Bull Confirmed If

An EPS of $0.70 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $0.65 would raise concerns about the company's profitability and growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±12.76%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a substantial move, suggesting that traders expect significant volatility around the earnings report.

Options are pricing ±3.1% while LMAT has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.4%

Calls (0)P/C Ratio: 12.00Puts (3K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 10 of 30 (33%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LeMaitre beats expectations, history suggests the stock could rise by around 0.06%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future guidance.

Miss

A miss could lead to a decline of about 1.80%, as seen in past reactions to earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in vascular technology.
2Details on market expansion strategies and geographic performance.
3Insights into cost management and gross margin trends.
4Management's outlook on competitive pressures in the health care equipment sector.
5Any commentary on regulatory changes affecting the industry.